Nuclear Medicine/Radiopharmaceuticals Market
                     Nuclear Medicine/Radiopharmaceuticals 
Market
Nuclear 
Medicine/Radiopharmace
uticals Market to 2027 - 
Global Analysis and 
Forecasts by Applications 
(Diagnostic Applications, 
Therapeutic 
Applications); End User 
(Hospitals, Diagnostic 
Centers) and Geography
Hemophilia Treatment Market 
Current and future Market Scenario
 According to The Insight Partners market research study titled 'Nuclear Medicine/Radiopharmaceuticals 
Market to 2027 – Global Analysis and Forecasts by Applications and End User'. The Global Nuclear 
Medicine/Radiopharmaceuticals Market is expected to reach US$ 6,683.99 Mn in 2027 from US$ 3,982.11 Mn 
in 2018.
  The market is estimated to grow with a CAGR of 6.2% from 2019-2027. The report highlights the trends 
prevalent in the global nuclear medicine/radiopharmaceuticals market and the factors driving the market 
along with those that act as deterrents to its growth.
 
 The market is estimated to grow with a CAGR of 6.2% from 2019-2027. The report highlights the trends 
prevalent in the global nuclear medicine/radiopharmaceuticals market and the factors driving the market 
along with those that act as deterrents to its growth.
 
 This segment is also expected to dominate the market in 2027 owing to availability of diagnostic devices and 
ease offered by these devices for diagnosis of various disorders. Moreover, increasing incidences of cardiac 
diseases, cancer, and neurological disorders are expected to fuel the demand for better diagnosis of these 
disorders.
Key Findings
 Also, nuclear medicine provide better diagnostic information about the functioning of a specific organ, as 
it uses radiation. Hence, owing to the above statements, this segment is also anticipated to witness the 
growth at a significant rate during the forecast period, 2019 to 2027.
 Market Insights
Rising Prevalence of Chronic Diseases
The chronic diseases such as heart diseases, cancer, chronic lung diseases, stroke, Alzheimer’s disease, and 
chronic kidney disease and other neurological disorders are growing at a rapid rate across the globe. These 
chronic diseases are the leading cause of deaths. According to the recent statistics of World Health 
Organization for the year 2019, states that chronic disease contributes approximately 60% of all deaths and 
43% of the global burden of disease. It is also expected that by 2020 the incidences of deaths will rise 
approximately to 73% and the global burden of disease is expected to grow by 60%.
Hemophilia Treatment Market 
 
Market Segments
By Application  
Diagnostic Applications    Therapeutic Applications
SPECT (Single-Photon By End UserThyroid
Emission Computed HospitalsBone Metastasis
Tomography) Applications Diagnostic CentersLymphoma
PET (Positron Emission Endocrine Tumors
Tomography) Applications Other Therapeutic 
Applications 
Hemophilia Treatment Market 
Dominating Segments
 
 The global nuclear medicine/radiopharmaceuticals market by application was led by diagnostic applications 
  segment. In 2018, the diagnostic applications segment held a largest market share of the nuclear 
medicine/radiopharmaceuticals market, by applications. This segment is also expected to dominate the 
market in 2027 owing to availability of diagnostic devices and ease offered by these devices for diagnosis of 
various disorders. Moreover, increasing incidences of cardiac diseases, cancer, and neurological disorders are 
expected to fuel the demand for better diagnosis of these disorders.
 The global nuclear medicine/radiopharmaceuticals market by end user segment was led by hospitals 
segment. In 2018, the hospitals settings segment with a significant share in the nuclear 
medicine/radiopharmaceuticals market, by end user. This segment is also expected to dominate the market 
in 2027 owing to presence of skilled professionals in hospitals, increasing preference for better healthcare 
facilities as well as availability of reimbursement policies.
 There have been limited developments made in the nuclear medicine/radiopharmaceuticals market during 
recent years. However, growth strategies such as approvals, collaborations, and partnerships have been 
witnessed in the market of nuclear medicine/radiopharmaceuticals. 
Dominating Segments
 Download PDF Brochure https://www.theinsightpartners.com/sample/TIPRE00003751/
 By Geography
 North America
 U.S.
 Canada
 Mexico
 Europe
 France
 Germany
 UK
 Spain
 Italy
Dominating Segments
 Asia Pacific (APAC)
 China
 India
 Japan
 Australia
 South Korea
 Middle East & Africa (MEA)
 Saudi Arabia
 South Africa
 UAE
 South and Central America
 Brazil
 Argentina 
Hemophilia Treatment Market  
Leading Players
 Company Profiles
Cardinal Health
IBA Worldwide
Curium
GENERAL ELECTRIC
Bayer AG
Positron Corporation
NTP Radioisotopes SOC Ltd.
Bracco
Lantheus Medical Imaging Inc.
Advanced Accelerator Applications
  REGIONAL FRAMEWORK
REGIONAL FRAMEWORK
  Hemophilia Treatment Market  
 
 
 Hemophilia Treatment Market 
 
 
        
Access Full Research Report at: 
https://www.theinsightpartners.com/reports/radiopharmaceuticals-market
Thank You! 
 Thank You!